Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
1. Verfasser: | Anderson, R |
---|---|
Weitere Verfasser: | Vallis, K |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
2021
|
Schlagworte: |
Ähnliche Einträge
Ähnliche Einträge
-
Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
von: REN Ya'nan, et al.
Veröffentlicht: (2020-12-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
von: Solmaz Mojarad-Jabali, et al.
Veröffentlicht: (2025-01-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
von: P. August Schubiger, et al.
Veröffentlicht: (2004-10-01) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
von: Paweł Szponar, et al.
Veröffentlicht: (2023-11-01) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
von: Alessio Rizzo, et al.
Veröffentlicht: (2022-11-01)